CRO Health Decisions carries on after CEO's death

North Carolina CRO Health Decisions is working its way back to normalcy after the death of its founder and CEO, processing a loss that "devastated" its staff, an executive said.

Michael Rosenberg, who founded the company in 1989, died last week after crashing a private plane into a house in the Maryland suburbs of Washington, DC, the company confirmed. The crash also claimed the lives of two passengers and three residents of the home, according to reports.

Now, as Health Decisions deals with the loss of its leader, the company is continuing its business operations without interruption, Clinical Affairs Vice President Patrick Phillips said. Over the past three years, Rosenberg had handed over day-to-day management duties to his executive team, Phillips said, and that staff remains in place.

"We can best honor Michael by carrying on and realizing his vision of a more efficient approach to clinical development," Phillips said in a statement. "We are committed to that goal."

The company said it plans to announce a succession plan "at an appropriate time," adding that it weighed on the future of its business only "in hopes that the focus of the tragedy can return to supporting those who were impacted."

According to the Triangle Business Journal, Rosenberg was on his way to a meeting with the FDA on the morning of the crash, and with him was Health Decisions employee Chijioke Ogbuka and David Hartman, a vice president at consulting outfit Nuventra.

- read Health Decisions' statements here and here
- check out the TBJ story

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.